Pathogenicinflammation in the CNS of mice carrying humanPLP1mutations
- 27 August 2016
- journal article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 25 (21) , 4686-4702
Abstract
Progressive forms of multiple sclerosis lead to chronic disability, substantial decline in quality of life and reduced longevity. It is often suggested that they occur independently of inflammation. Here we investigated disease progression in mouse models carrying PLP1 point mutations previously found in patients displaying clinical features of multiple sclerosis. These mouse models show loss-of-function of PLP1 associated with neuroinflammation; the latter leading to clinically relevant axonal degeneration, neuronal loss and brain atrophy as demonstrated by inactivation of the recombination activating gene 1. Moreover, these pathological hallmarks were substantially amplified when we attenuated immune regulation by inactivation of the programmed cell death-1 gene. Our observations support the view that primary oligodendroglial abnormalities can evoke pathogenically relevant neuroinflammation that drives neurodegeneration, as observed in some forms of multiple sclerosis but also in other, genetically-mediated neurodegenerative disorders of the human nervous system. As many potent immunomodulatory drugs have emerged during the last years, it is tempting to consider immunomodulation as a treatment option not only for multiple sclerosis, but also for so far non-treatable, genetically-mediated disorders of the nervous system accompanied by pathogenic neuroinflammation.Keywords
This publication has 64 references indexed in Scilit:
- Pathology and disease mechanisms in different stages of multiple sclerosisJournal of the Neurological Sciences, 2013
- Treatment trials in progressive MS—current challenges and future directionsNature Reviews Neurology, 2013
- Pathoetiology of multiple sclerosis: are we barking up the wrong tree?F1000Prime Reports, 2013
- Regulation of Microglial Proliferation during Chronic NeurodegenerationThe Journal of Neuroscience, 2013
- Progressive multiple sclerosis: pathology and pathogenesisNature Reviews Neurology, 2012
- Will the real multiple sclerosis please stand up?Nature Reviews Neuroscience, 2012
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?The Lancet Neurology, 2009
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?Annual Review of Neuroscience, 2008
- Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral SclerosisJournal of Neuroscience, 2004